DJ4, a multi-kinase inhibitor of both ROCK and MRCK, inhibited migration and invasion of lung, breast, melanoma, and pancreatic cancer cells (Kale et al. 2014). This evidence concerns the gene CDC42BPA and pancreatic neoplasm.